Requiring Infant Formula, Medical Food Shortage Updates Included In US FDA Budget Request
Executive Summary
FDA’s justification report published with Biden administration’s FY2022 federal budget request includes $1.194bn for agency’s food programs, which include its oversight of supplement industry, up from $1.11bn in FY2021 appropriation.
You may also be interested in...
US FDA ‘Closer To Zero’ Meeting On Infant Nutrition Safety And Benefits Set For November
CFSAN launched “C2Z” initiative in April following widespread reports of contamination of baby food products. Agency officials will outline C2Z plan including a four-stage approach for continual improvement and additional work related to levels of toxic elements in food.
US House Appropriators Have Little Left To Say About Allowing Cannabinoids In Supplements
Appropriation Committee’s report with FDA’s FY2022 funding bill appears to signal that other than getting something done, members have little to say about establishing lawful use of hemp-derived cannabinoids in non-drug products.
House Appropriators Go Low On FDA's Budget
Appropriation set for CFSAN and ORA’s related field activities is $1.16bn, up slightly from the FY2021 level of $1.1bn, and for CDER and ORA’s related activities is $2.1bn, up $100m from current funding.